Clinical Trial Update: Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion of melphalan with hepatic perfusion for unresectable liver cancer has been completed. The study assessed sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Cancer | Phase 2 | Status: COMPLETED